Chemoimmunotherapy combination study on mice looks promising

A combination of an immunotherapy agent and an approved low dose chemo oxaliplatin work well in early mouse study.

www.sciencetimes.com/articles/5951/20150429/new-chemoimmunotherapy-proves-potent-against-prostate-cancers.htm

www.nature.com/nature/journal/vaop/ncurrent/full/nature14395.html

Post Edited (robertC) : 4/30/2015 8:08:14 AM (GMT-6)

Well research has to start somewhere, as John Steinbeck knew in prescient way!! Back to the shop?